Here’s what’s making health news this morning:
FDA Grants Approval to Diet Pill From Vivus (WSJ): Approval of Vivus’s weight-loss drug Qsymia marks the second approval of a new weight-loss drug in less than a month; the drugs, which require a doctor’s prescription, won’t be available until later this year.
Immune Drug Shows Promise for Alzheimer’s (WSJ): A tiny but promising new study suggests that a medicine already on the market, intravenous immunoglobulin therapy, or IVIG, may offer benefits to Alzheimer’s patients—a result likely to spur interest in using the therapy off-label even though it is in limited supply.
SanDisk Ultra 64 GB MicroSDXC Class 10 UHS-1 Memor...
(4836) 
45 days in the top 100 
(2169) 
55 days in the top 100 Platform: 
Windows 
(592) 
(544) 
Comments on this entry are closed.